• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AIA
Click for more information
0.67% $7.44

Auckland International Airport Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Industrials Airports & Air Services

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AIA
Ann: AIA - AUD FX for FY24 final dividend 		02/10/24 0 77
02/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  77 
AIA
Ann: Auckland International Airport Ltd ("AIA230") - Maturity 		20/09/24 0 70
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  70 
AIA
Ann: AIA - Capital Change Notice for Placement 		20/09/24 0 53
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  53 
AIA
Ann: AIA - ASX Appendix 2A 		19/09/24 0 47
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  47 
AIA
Ann: AIA - announces opening of $200 million Retail Offer 		19/09/24 0 93
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  93 
AIA
Ann: AIA - Trading to resume at 11:36am 		17/09/24 0 62
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  62 
AIA
Ann: AIA - $1.2 billion Placement Fully Subscribed 		17/09/24 0 89
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  89 
AIA
Ann: AIA - ASX Appendix 3B 		16/09/24 0 65
16/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  65 

See All Discussions arrow Created with Sketch.

Featured News

LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
right-arrow Created with Sketch.
NEWS Key permitting milestone reached for Antler Copper Project as air quality application moves to substantive review, pushing development forward
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
(20min delay)
Last
$7.44 		Change
-0.050(0.67%) 		Mkt cap ! n/a
Open High Low Value Volume
$7.40 $7.46 $7.38 $7.795M 1.048M

Buyers (Bids)

No. Vol. Price($)
0 1200 $7.32
 

Sellers (Offers)

Price($) Vol. No.
$7.49 743 0
Last trade - 11.00am 04/10/2024 (20 minute delay) ?
AIA (NZSX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Neurotech knocked back by FDA as agency declares target condition not rare enough for special status Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.
Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation After just over a week, the thrill China’s latest stimulus announcements put into world markets has started to subside.

Featured News

NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
right-arrow Created with Sketch.
CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.